EGFR and neoplasm: Fueling this caveat is a binary problem whereby i) the identities of ECM protein(s) that mechanosensitize EGFR toward tumor stiffness remain elusive; and ii) the functional regulatory pathway of EGFR on these ECM proteins that crosstalk with tumor‐mechanotransduction network is not well defined.